Top

World Journal of Surgery

Published in:

01-08-2009

Extension of Nonoperative Management of Blunt Pancreatic Trauma to Include Grade III Injuries: A Safety Analysis

Authors: Giacomo Pata, Claudio Casella, Ernesto Di Betta, Luigi Grazioli, Bruno Salerni

Published in: World Journal of Surgery | Issue 8/2009

Abstract

Background

In hemodynamically stable patients after blunt pancreatic trauma, the main pancreatic duct (MPD) disruption (American Association for the Surgery of Trauma [AAST] grade III-IV-V lesions) is usually treated surgically or by endoscopic stent placement, whereas injuries without duct involvement (grade I-II) are liable to medical treatment. To date, no evidence has been reported regarding nonoperative management (NoM) of grade III injuries. We aimed to evaluate the safety of extending medical management to include cases of distal MPD involvement (grade III).

Patients and methods

Data were collected on patients admitted after blunt pancreatic trauma between January 1999 and December 2007. Patients exhibiting hemodynamic instability or hollow organ perforations were excluded from this study, as they were surgically managed. In all remaining cases NoM was attempted. Antibiotic prophylaxis and early total enteral nutrition were routinely adopted. Grade III patients received octreotide during hospitalization and for 6 months after discharge.

Results

Eleven patients (2 with grade I injury, 3 with grade II injury, and 6 with grade III injury, all diagnosed by contrast-enhanced helical CT) were included. Nonsurgical management was carried out in all of these patients. Among grade III patients, one developed a peripancreatic abscess; another, a pancreatic fistula. Both were successfully treated nonoperatively. The average length of hospital stay was similar in grade I-II and grade III patients. After a median follow-up of 57 months no mortality or pancreatic sequelae had occurred.

Conclusions

Under the aforementioned conditions, an attempt to extend NoM to include patients with AAST-grade III lesions can be justified. However, such a strategy demands continuous patient monitoring, because should the case worsen, surgery might become necessary.

Lin BC, Chen RJ, Fang JF et al (2004) Management of blunt major pancreatic injury. J Trauma 56:774–778PubMedCrossRef

Wolf A, Bernhardt J, Patrzyk M et al (2005) The value of endoscopic diagnosis and the treatment of pancreas injuries following blunt abdominal trauma. Surg Endosc 19:665–669PubMedCrossRef

Tyburski JG, Dente CJ, Wilson RF et al (2001) Infectious complications following duodenal and/or pancreatic trauma. Am Surg 67:227–231PubMed

Wong YC, Lj Wang, Lin BC et al (1997) CT grading of blunt pancreatic injuries: prediction of ductal disruption and surgical correlation. J Comput Assist Tomogr 21:246–250PubMedCrossRef

Ilahi O, Bochicchio GV, Scalea TM (2002) Efficacy of computed tomography in the diagnosis of pancreatic injuries in adult blunt trauma patients: a single-institutional study. Am Surg 68:704–708PubMed

Akhrass R, Yaffe MB, Brandt CP et al (1997) Pancreatic trauma: a ten-year multi-institutional experience. Am Surg 63:598–604PubMed

Madida TE, Mokoena TR (1995) Favorable prognosis after surgical drainage of gunshot, stab or blunt trauma of the pancreas. Br J Surg 82:1236–1239CrossRef

Bradley EL 3rd, Young PR Jr, Chang MC et al (1998) Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multi-institutional review. Ann Surg 227:861–869PubMedCrossRef

Ryan S, Sandler A, Trenhaile S et al (1994) Pancreatic enzyme elevations after blunt trauma. Surgery 116:622–627PubMed

10.

Lane MJ, Mindelnuz RE, Jeffrey RB (1996) Diagnosis of pancreatic injury after blunt abdominal trauma. Semin Ultrasound CT MR 17:177–182PubMedCrossRef

11.

Shilyansky J, Sena LM, Kreller M et al (1998) Nonoperative management of pancreatic injuries in children. J Pediatr Surg 33:343–349PubMedCrossRef

12.

Kouchi K, Tanabe M, Yoshida H et al (1999) Nonoperative management of blunt pancreatic injury in childhood. J Pediatr Surg 34:1736–1739PubMedCrossRef

13.

Wales PW, Shuckett B, Kim PCW (2001) Long-term outcome after nonoperative management of complete traumatic pancreatic transection in children. J Pediatr Surg 36:823–827PubMedCrossRef

14.

Wong YC, Wang LJ, Fang JF et al (2008) Multidetector-row computed tomography (CT) of blunt pancreatic injuries: can contrast-enhanced multiphasic CT detect pancreatic duct injuries? J Trauma 64:666–672PubMedCrossRef

15.

Fulcher AS, Turner MA, Yelon JA et al (2000) Magnetic resonance cholangiopancreatography (MRCP) in the assessment of pancreatic duct trauma and its sequelae: preliminary findings. J Trauma 48:1001–1007PubMedCrossRef

16.

Bofferd KD, Brooks AJ (2000) Pancreatic trauma—injuries to the pancreas and pancreatic duct. Eur J Surg 166:4–12

17.

Teh SH, Sheppard BC, Mullins RJ et al (2007) Diagnosis and management of blunt pancreatic ductal injury in the era of high-resolution computed axial tomography. Am J Surg 193:641–643PubMedCrossRef

18.

Eimiller A (1992) Complication in endoscopy (review). Endoscopy 24:176–184PubMedCrossRef

19.

Collen MJ, Hanan MR, Maher JA et al (1980) Modification of endoscopic retrograde cholangiopancreatography (ERCP) septic complications by the addition of an antibiotic to the contrast media: randomized controlled investigation. Am J Gastroenterol 74:493–496PubMed

20.

Thomopoulos KC, Pagoni NA, Vagenas KA et al (2006) Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc 64:726–731PubMedCrossRef

21.

Andriulli A, Leandro G, Niro G et al (2000) Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51:100–103CrossRef

22.

Foster E, Leung J (2007) Pharmacotherapy for the prevention of post-ERCP pancreatitis. Am J Gastroenterol 102:52–55PubMedCrossRef

23.

Hardt PD, Kress O, Fadgyas T et al (2000) Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy. Eur J Med Res 5:165–170PubMed

24.

Poon RT, Fan ST (2003) Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results. JOP 4:33–40PubMed

25.

Andriulli A, Leandro G, Clemente R et al (1998) Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 12:237–245PubMedCrossRef

26.

Cavallini G, Frulloni L (2001) Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 33:192–201PubMedCrossRef

27.

Uhl W, Buchler MW, Malfertheiner P et al (1999) A randomized, double blind, multicentric trial of octreotide in moderate to severe acute pancreatitis. Gut 45:97–104PubMed

28.

Gouillat C, Gigot JF (2001) Pancreatic surgical complications-the case for prophylaxis. Gut 49(Suppl 4):32–39

29.

Hesse UJ, DeDecker C, Houtmeyers P et al (2005) Prospectively randomized trial using perioperative low-dose octreotide to prevent organ-related and general complications after pancreatic surgery and pancreatico-jejunostomy. World J Surg 29:1325–1328PubMedCrossRef

30.

Zeng Q, Zhang Q, Han S et al (2008) Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Pancreas 36:18–25PubMedCrossRef

31.

Morgan KA, Adams DB (2007) Management of internal and external pancreatic fistulas. Surg Clin North Am 87:1503–1513PubMedCrossRef

32.

Vasquez JC, Coimbra R, Hoyt DB et al (2001) Management of penetrating pancreatic trauma: an 11-year experience of a level-1 trauma center. Injury 32:753–759PubMedCrossRef

33.

O’Toole D, Vullierme MP, Ponsot P et al (2007) Diagnosis and management of pancreatic fistulae resulting in pancreatic ascites or pleural effusions in the era of helical CT and magnetic resonance imaging. Gastroenterol Clin Biol 31:686–693PubMed

34.

Uchiyama T, Suzuki T, Adachi A et al (1992) Pancreatic pleural effusion: case report and review of 113 cases in Japan. Am J Gastroenterol 87:387–391PubMed

35.

Dhebri AR, Ferran N (2005) Nonsurgical management of pancreaticopleural fistula. JOP 6:152–161PubMed

36.

Amirada E, Livingston DH, Elcavage J (1994) Octreotide acetate decreases pancreatic complications after pancreatic trauma. Am J Surg 168:345–347CrossRef

37.

Ohge H, Yokoyama T, Kodama T et al (1999) Surgical approaches for pancreatic ascites: report of three cases. Surg Today 29:458–461PubMedCrossRef

38.

Munshi IA, Haworth R, Barie PS (1995) Resolution of refractory pancreatic ascites after continuous infusion of octreotide acetate. Int J Pancreatol 17:203–206PubMed

39.

Gislason H, Gronbech JE, Soreide O (1991) Pancreatic ascites: treatment by continuous somatostatin infusion. Am J Gastroenterol 86:519–521PubMed

40.

Lin BC, Liu NJ, Fang JF et al (2006) Long-term results of endoscopic stent in the management of blunt major pancreatic duct injury. Surg Endosc 20:1551–1555PubMedCrossRef

41.

Moore EE, Jones TN (1986) Benefits of immediate jejunostomy feeding after major abdominal trauma—a prospective randomized trial. J Trauma 26:874–881PubMedCrossRef

42.

Kudsk KA, Croce MA, Fabian TC et al (1992) Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 215:503–513PubMedCrossRef

43.

Gupta R, Patel K, Calder PC et al (2003) A randomised clinical trial to assess the effect of total enteral and total parenteral nutritional support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II ≥ 6). Pancreatology 3:406–413PubMedCrossRef

44.

Abou-Assi S, Craig K, O’Keefe SJ (2002) Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Am J Gastroenterol 97:2255–2262PubMedCrossRef

45.

Olah A, Pardavi G, Belagyi T et al (2002) Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate. Nutrition 18:259–262PubMedCrossRef

46.

Windsor AC, Kanwar S, Li AG et al (1998) Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 42:431–435PubMedCrossRef

47.

McClave SA, Greene LM, Snider HL et al (1997) Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis. JPEN J Parenter Enteral Nutr 21:14–20PubMedCrossRef

48.

Kalfarentzos F, Kehagias J, Mead N et al (1997) Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 84:1665–1669PubMedCrossRef

Title: Extension of Nonoperative Management of Blunt Pancreatic Trauma to Include Grade III Injuries: A Safety Analysis
Authors: Giacomo Pata
Claudio Casella
Ernesto Di Betta
Luigi Grazioli
Bruno Salerni
Publication date: 01-08-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 8/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-009-0082-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Extension of Nonoperative Management of Blunt Pancreatic Trauma to Include Grade III Injuries: A Safety Analysis

Abstract

Background

Patients and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Patients and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2009

Contributions of Australian Surgeons to the Development of the Laparoscopic Upper Gastrointestinal Surgery Revolution: A Narrative

The Role of the Platelet-Rich Plasma in Accelerating the Wound-Healing Process and Recovery in Patients Being Operated for Pilonidal Sinus Disease: Preliminary Results

Appraising the Quality of Care in Surgery

Risk Factors for Complications After Laparoscopic Surgery in Colorectal Cancer Patients: Experience of 401 Cases at a Single Institution

Value of MELD and MELD-Based Indices in Surgical Risk Evaluation of Cirrhotic Patients: Retrospective Analysis of 190 Cases

Successful Treatment of Traumatic Neuroma